ALLMedicine™ Alg12-cdg Center
Research & Reviews 4 results
https://doi.org/10.1016/j.braindev.2021.05.013
Brain & Development; Hiraide T, Wada Y et. al.
Jun 8th, 2021 - ALG12-CDG is a rare autosomal recessive type I congenital disorder of glycosylation (CDG) due to pathogenic variants in ALG12 which encodes the dolichyl-P-mannose:Man-7-GlcNAc-2-PP-dolichyl-alpha-6-mannosyltransferase. Thirteen patients from unrel...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434597
Molecular Genetics & Genomic Medicine; de la Morena-Barrio ME, Sabater M et. al.
Jun 13th, 2020 - Congenital disorder of glycosylation (CDG) type I is a group of rare disorders caused by recessive mutations in up to 25 genes that impair the N-glycan precursor formation and its transfer to proteins resulting in hypoglycosylation of multiple pro...
https://doi.org/10.1007/s10545-016-9954-9
Journal of Inherited Metabolic Disease; Monticelli M, Ferro T et. al.
Jul 10th, 2016 - Congenital disorders of glycosylation (CDG) are a rapidly growing family of genetic diseases comprising more than 85 known distinct disorders. They show a great phenotypic variability ranging from multi-organ/system to mono-organ/system involvemen...
https://rarediseases.info.nih.gov/diseases/9833/alg12-cdg-cdg-ig
Jul 1st, 2016 - The following summary is from Orphanet, a European reference portal for information on rare diseases and orphan drugs. Orpha Number: 79324 Definition A form of congenital disorders of N-linked glycosylation characterized by facial dysmorphism (pro...
